Investor profile
Sanne Weijzen
Corporate VC & Head of Cell Therapy Business and Portfolio Strategy at AstraZeneca
Sanne Weijzen is a Head of Cell Therapy Business and Portfolio Strategy at AstraZeneca, whose known portfolio counts 12 companies.
Is Sanne Weijzen a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Head of Cell Therapy Business and Portfolio Strategy at AstraZeneca, whose known portfolio counts 12 companies
- Syneron
- HUMA
- Nucleus RadioPharma
- Asher Bio
- Creech Medical Technology Development
- Rgenta Therapeutics
- SmartCella
- Axbio
- Cellectis
- GenAssist Therapeutics
- Promise Bio
- SixPeaks Bio
Investor Profile
Sanne Weijzen is listed against sector Healthcare, and focus areas Biotech, Corporate-Strategic, Diagnostics and Drug Discovery in the database.
Stage-wise, the deals at AstraZeneca cluster around Growth, Late-Stage and Seed rounds.
What the affiliated firm has backed is the closest available signal on whether Sanne Weijzen is worth approaching.
Colleagues at AstraZeneca
Maya Leo Aridi
Venture Capital
Washington, United States
Alexander Kvist
Senior Project Leader, Bioventure Innovation Unit
Gothenburg, Sweden
Ulrika Edvardsson
Managing Director BioVentureHub
Gothenburg, Sweden
Preya Subramoney
Senior Medical Director
Denmark
Demi Weldon
Executive Director
San Francisco, United States
Peter Fenici
Head of Medical Innovation
Italy
Cherry Zhang
Associate Director
Singapore
Pernilla Isberg
Director BioVentureHub
Gothenburg, Sweden
Annie Vemu
Director, CI New Technologies & Platforms
Boston, United States
Laura Wright
Managing Partner FTS
Washington, United States
Crystal Brooks
Corporate Ventures Associate Director
United States
André Verhoek
Principial and founder, PhD Candidate
Barcelona, Spain
Frank Qin
Investor
United States
Daniel Johansson
Project Leader
Kungsbacka, Sweden
Robert Roth
Science Director BioVentureHub
Gothenburg, Sweden
Yani Wang
Director, Venture Investment & BD
Ithaca, United States
Frequently asked questions
Who is Sanne Weijzen?
Sanne Weijzen is a corporate venture investor based in Hilversum, Netherlands, listed as Head of Cell Therapy Business and Portfolio Strategy at AstraZeneca. The known portfolio of that firm counts 12 companies. That portfolio belongs to the firm, not to Sanne Weijzen personally.
What does Sanne Weijzen invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Corporate-Strategic, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Sanne Weijzen invest at?
AstraZeneca appears in Growth, Late-Stage and Seed rounds across its known deals, and Sanne Weijzen is listed there as Head of Cell Therapy Business and Portfolio Strategy. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Sanne Weijzen listed at?
Sanne Weijzen is listed as Head of Cell Therapy Business and Portfolio Strategy at AstraZeneca. 16 other people in the database share a firm with Sanne Weijzen.
How do I contact Sanne Weijzen?
A phone number and a LinkedIn page are on file for Sanne Weijzen. They are readable inside RaiseHunt after you create an account. The database holds no email address for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal